Hongxia Wang

1 clinical trials · Sponsor

Record	Firm	Date
A Randomized, Self-controlled Post-marketing Clinical Study on the Comparison of Shengbai Oral Liquid and Leucogen Tablets in the Treatment of Moderate Neutropenia Caused by Anti-tumor Drugs in Breast Cancer Patients (NCT07578064)	Hongxia Wang	2025-08-06

Every clearance here is in the API, with alerts when new ones post.